Sven Karlsson is the co-founder, chief operating officer and chief business officer of Platelet BioGenesis. He has more than a decade of experience in business development and financial analysis.
In this episode of Biotech2050, Sven talks about his background, how he came to founding Platelet BioGenesis and the problems he and his team are trying to solve with the world's only method of producing clinical-grade human platelets from induced pluripotent stem cells.
Read MoreDr. Jo Viney is an entrepreneurial scientist and experienced biotech executive. A self-described “drug-hunter”, she has successfully advanced a number of programs into the clinic.
She is the is Co-Founder, President and CSO of Pandion Therapeutics, a biotech company focused on developing new therapies for treating autoimmune and inflammatory diseases.
Read MoreJohn Keilty is the Chief Data Sciences Officer at Decibel Therapeutics and a Strategic advisor at Third Rock Ventures. He is a biologist and bioinformatics guy by training and has been active in the biotech space for over two decades. In his career, John has been responsible for building out genomix, and genetics capabilities for early stage biotech companies.
Read MoreIn this inaugural episode of Biotech2050, hosts Alok Tayi and Rahul Chatuverdi sits down with Lee Cooper, a seasoned biotech entrepreneur, patient advocate, and Founder of Enlight Bio to talk about the importance of patient centricity in today’s modern biotech.
Read MoreThis episode is the trailer launching our highly anticipated podcast, Biotech 2050. A Think Tank chronicling the disruptions changing the biotech industry over the next 50 years.
Read More
